{"entity":{"type":"insider","cik":"0001468223","url":"/insider/0001468223","json_url":"/insider/0001468223.json","name":"MVA Investors, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":66,"n_filings":26,"first":"2013-08-20","last":"2024-07-02","span_basis":"filed_date"},"name_variants":[{"name":"MVA Investors, LLC","source":"filing","n_filings":26,"first_seen":"2013-08-20","last_seen":"2024-07-02"}],"transactions":[{"id":2035039,"accession":"0000895345-24-000245","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000895345-24-000245","line_url":"/filing/0000895345-24-000245#line-3","is_derivative":false,"issuer_cik":"0001465914","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001465914","owner_cik":null,"owner_name":"Davis Aaron I.; MVA Investors, LLC","owner_display_name":"Davis Aaron I.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95000.0,"shares_display":"95,000","price_per_share":8.68,"price_display":"8.68","price_state":"stated","total_value":824600.0,"total_display":"824,600.00","total_whole":"824,600","shares_owned_after":108793.0,"shares_owned_after_display":"108,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-02","filed_date":"2024-07-02","scope":"insider"},{"id":2035038,"accession":"0000895345-24-000245","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-24-000245","line_url":"/filing/0000895345-24-000245#line-2","is_derivative":false,"issuer_cik":"0001465914","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001465914","owner_cik":null,"owner_name":"Davis Aaron I.; MVA Investors, LLC","owner_display_name":"Davis Aaron I.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110731.0,"shares_display":"110,731","price_per_share":8.87,"price_display":"8.87","price_state":"stated","total_value":982183.97,"total_display":"982,183.97","total_whole":"982,184","shares_owned_after":203793.0,"shares_owned_after_display":"203,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-02","scope":"insider"},{"id":2035037,"accession":"0000895345-24-000245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000895345-24-000245","line_url":"/filing/0000895345-24-000245#line-1","is_derivative":false,"issuer_cik":"0001465914","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001465914","owner_cik":null,"owner_name":"Davis Aaron I.; MVA Investors, LLC","owner_display_name":"Davis Aaron I.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29000.0,"shares_display":"29,000","price_per_share":8.57,"price_display":"8.57","price_state":"stated","total_value":248530.0,"total_display":"248,530.00","total_whole":"248,530","shares_owned_after":314524.0,"shares_owned_after_display":"314,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-28","filed_date":"2024-07-02","scope":"insider"},{"id":2499727,"accession":"0000895345-24-000225","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-24-000225","line_url":"/filing/0000895345-24-000225#line-2","is_derivative":false,"issuer_cik":"0001465914","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001465914","owner_cik":null,"owner_name":"Davis Aaron I.; MVA Investors, LLC","owner_display_name":"Davis Aaron I.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77000.0,"shares_display":"77,000","price_per_share":6.88,"price_display":"6.88","price_state":"stated","total_value":529760.0,"total_display":"529,760.00","total_whole":"529,760","shares_owned_after":343524.0,"shares_owned_after_display":"343,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-07","filed_date":"2024-06-07","scope":"insider"},{"id":2499722,"accession":"0000895345-24-000225","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000895345-24-000225","line_url":"/filing/0000895345-24-000225#line-1","is_derivative":false,"issuer_cik":"0001465914","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001465914","owner_cik":null,"owner_name":"Davis Aaron I.; MVA Investors, LLC","owner_display_name":"Davis Aaron I.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63000.0,"shares_display":"63,000","price_per_share":7.24,"price_display":"7.24","price_state":"stated","total_value":456120.0,"total_display":"456,120.00","total_whole":"456,120","shares_owned_after":420524.0,"shares_owned_after_display":"420,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-06","filed_date":"2024-06-07","scope":"insider"},{"id":2975586,"accession":"0000895345-24-000151","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000895345-24-000151","line_url":"/filing/0000895345-24-000151#line-3","is_derivative":false,"issuer_cik":"0001465914","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001465914","owner_cik":null,"owner_name":"Davis Aaron I.; MVA Investors, LLC","owner_display_name":"Davis Aaron I.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":7.61,"price_display":"7.61","price_state":"stated","total_value":456600.0,"total_display":"456,600.00","total_whole":"456,600","shares_owned_after":483524.0,"shares_owned_after_display":"483,524","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-03","filed_date":"2024-05-03","scope":"insider"},{"id":2975583,"accession":"0000895345-24-000151","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-24-000151","line_url":"/filing/0000895345-24-000151#line-2","is_derivative":false,"issuer_cik":"0001465914","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001465914","owner_cik":null,"owner_name":"Davis Aaron I.; MVA Investors, LLC","owner_display_name":"Davis Aaron I.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":7.56,"price_display":"7.56","price_state":"stated","total_value":567000.0,"total_display":"567,000.00","total_whole":"567,000","shares_owned_after":543524.0,"shares_owned_after_display":"543,524","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-03","scope":"insider"},{"id":2975578,"accession":"0000895345-24-000151","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000895345-24-000151","line_url":"/filing/0000895345-24-000151#line-1","is_derivative":false,"issuer_cik":"0001465914","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001465914","owner_cik":null,"owner_name":"Davis Aaron I.; MVA Investors, LLC","owner_display_name":"Davis Aaron I.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":7.43,"price_display":"7.43","price_state":"stated","total_value":557250.0,"total_display":"557,250.00","total_whole":"557,250","shares_owned_after":618524.0,"shares_owned_after_display":"618,524","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-01","filed_date":"2024-05-03","scope":"insider"},{"id":9203170,"accession":"0000895345-23-000589","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-23-000589","line_url":"/filing/0000895345-23-000589#line-2","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":6.84,"price_display":"6.84","price_state":"stated","total_value":3420000.0,"total_display":"3,420,000.00","total_whole":"3,420,000","shares_owned_after":8198642.0,"shares_owned_after_display":"8,198,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-16","filed_date":"2023-10-17","scope":"insider"},{"id":7833673,"accession":"0000895345-23-000588","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-23-000588","line_url":"/filing/0000895345-23-000588#line-2","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":6.84,"price_display":"6.84","price_state":"stated","total_value":3420000.0,"total_display":"3,420,000.00","total_whole":"3,420,000","shares_owned_after":8198642.0,"shares_owned_after_display":"8,198,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-16","filed_date":"2023-10-17","scope":"insider"},{"id":9203171,"accession":"0000895345-23-000589","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000895345-23-000589","line_url":"/filing/0000895345-23-000589#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750000.0,"shares_display":"750,000","price_per_share":7.07,"price_display":"7.07","price_state":"stated","total_value":5302500.0,"total_display":"5,302,500.00","total_whole":"5,302,500","shares_owned_after":7698642.0,"shares_owned_after_display":"7,698,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-13","filed_date":"2023-10-17","scope":"insider"},{"id":7833669,"accession":"0000895345-23-000588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000895345-23-000588","line_url":"/filing/0000895345-23-000588#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750000.0,"shares_display":"750,000","price_per_share":7.07,"price_display":"7.07","price_state":"stated","total_value":5302500.0,"total_display":"5,302,500.00","total_whole":"5,302,500","shares_owned_after":7698642.0,"shares_owned_after_display":"7,698,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-13","filed_date":"2023-10-17","scope":"insider"},{"id":7854388,"accession":"0000895345-23-000574","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-23-000574","line_url":"/filing/0000895345-23-000574","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":225000.0,"shares_display":"225,000","price_per_share":9.956666666666667,"price_display":"9.96","price_state":"stated","total_value":2240250.0,"total_display":"2,240,250.00","total_whole":"2,240,250","shares_owned_after":6948642.0,"shares_owned_after_display":"6,948,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-09","filed_date":"2023-10-11","scope":"insider","n_lines":2},{"id":8644021,"accession":"0000895345-23-000499","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-23-000499","line_url":"/filing/0000895345-23-000499","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; Dissanayake Shehan Bharatha; Fuglesang Christopher; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1258973.0,"shares_display":"1,258,973","price_per_share":27.8,"price_display":"27.80","price_state":"stated","total_value":34999449.4,"total_display":"34,999,449.40","total_whole":"34,999,449","shares_owned_after":3201440.0,"shares_owned_after_display":"3,201,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-15","scope":"insider","n_lines":2},{"id":8619788,"accession":"0000895345-23-000498","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000895345-23-000498","line_url":"/filing/0000895345-23-000498#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":475000.0,"shares_display":"475,000","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":2446250.0,"total_display":"2,446,250.00","total_whole":"2,446,250","shares_owned_after":743542.0,"shares_owned_after_display":"743,542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-15","scope":"insider"},{"id":8421038,"accession":"0000895345-23-000500","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-23-000500","line_url":"/filing/0000895345-23-000500","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Asset Management Inc.; Boxer Capital, LLC; Davis Aaron I.; Dissanayake Shehan Bharatha; Fuglesang Christopher; LEWIS JOSEPH; MVA Investors, LLC","owner_display_name":"Boxer Asset Management Inc.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1258973.0,"shares_display":"1,258,973","price_per_share":27.8,"price_display":"27.80","price_state":"stated","total_value":34999449.4,"total_display":"34,999,449.40","total_whole":"34,999,449","shares_owned_after":3201440.0,"shares_owned_after_display":"3,201,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-15","scope":"insider","n_lines":2},{"id":8619787,"accession":"0000895345-23-000107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000895345-23-000107","line_url":"/filing/0000895345-23-000107#line-2","is_derivative":false,"issuer_cik":"0001465914","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001465914","owner_cik":null,"owner_name":"Davis Aaron I.; MVA Investors, LLC","owner_display_name":"Davis Aaron I.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65568.0,"shares_display":"65,568","price_per_share":13.4,"price_display":"13.40","price_state":"stated","total_value":878611.2,"total_display":"878,611.20","total_whole":"878,611","shares_owned_after":22527.0,"shares_owned_after_display":"22,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-10","filed_date":"2023-02-13","scope":"insider"},{"id":8619784,"accession":"0000895345-23-000107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000895345-23-000107","line_url":"/filing/0000895345-23-000107#line-1","is_derivative":false,"issuer_cik":"0001465914","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001465914","owner_cik":null,"owner_name":"Davis Aaron I.; MVA Investors, LLC","owner_display_name":"Davis Aaron I.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":13.1,"price_display":"13.10","price_state":"stated","total_value":2620000.0,"total_display":"2,620,000.00","total_whole":"2,620,000","shares_owned_after":88095.0,"shares_owned_after_display":"88,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-09","filed_date":"2023-02-13","scope":"insider"},{"id":6364928,"accession":"0000899243-22-033595","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-033595","line_url":"/filing/0000899243-22-033595#line-3","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Davis Aaron I.; Boxer Capital, LLC; Boxer Asset Management Inc.; LEWIS JOSEPH","owner_display_name":"MVA Investors, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70000.0,"shares_display":"70,000","price_per_share":4.6461,"price_display":"4.65","price_state":"stated","total_value":325227.0,"total_display":"325,227.00","total_whole":"325,227","shares_owned_after":7123642.0,"shares_owned_after_display":"7,123,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-13","scope":"insider"},{"id":6364927,"accession":"0000899243-22-033595","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-033595","line_url":"/filing/0000899243-22-033595#line-2","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Davis Aaron I.; Boxer Capital, LLC; Boxer Asset Management Inc.; LEWIS JOSEPH","owner_display_name":"MVA Investors, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":4.4328,"price_display":"4.43","price_state":"stated","total_value":221640.0,"total_display":"221,640.00","total_whole":"221,640","shares_owned_after":268524.0,"shares_owned_after_display":"268,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-12","filed_date":"2022-10-13","scope":"insider"},{"id":6364926,"accession":"0000899243-22-033595","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-033595","line_url":"/filing/0000899243-22-033595#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Davis Aaron I.; Boxer Capital, LLC; Boxer Asset Management Inc.; LEWIS JOSEPH","owner_display_name":"MVA Investors, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":117000.0,"shares_display":"117,000","price_per_share":4.2539,"price_display":"4.25","price_state":"stated","total_value":497706.3,"total_display":"497,706.30","total_whole":"497,706","shares_owned_after":218524.0,"shares_owned_after_display":"218,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-11","filed_date":"2022-10-13","scope":"insider"},{"id":6913244,"accession":"0000899243-22-001072","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000899243-22-001072","line_url":"/filing/0000899243-22-001072","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC; Boxer Asset Management Inc.","owner_display_name":"Boxer Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":184677.0,"shares_display":"184,677","price_per_share":42.76798763462694,"price_display":"42.77","price_state":"stated","total_value":7898263.6524,"total_display":"7,898,263.65","total_whole":"7,898,264","shares_owned_after":3767405.0,"shares_owned_after_display":"3,767,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-05","scope":"insider","n_lines":8},{"id":6913206,"accession":"0000899243-22-001072","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-001072","line_url":"/filing/0000899243-22-001072","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; MVA Investors, LLC; Boxer Asset Management Inc.","owner_display_name":"Boxer Capital, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":515323.0,"shares_display":"515,323","price_per_share":47.88720607774153,"price_display":"47.89","price_state":"stated","total_value":24677378.6976,"total_display":"24,677,378.70","total_whole":"24,677,379","shares_owned_after":3912113.0,"shares_owned_after_display":"3,912,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-05","scope":"insider","n_lines":6},{"id":5455670,"accession":"0000899243-21-036419","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-036419","line_url":"/filing/0000899243-21-036419#line-3","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Tyra Biosciences, Inc.","issuer_ticker":"TYRA","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Davis Aaron I.; MVA Investors, LLC; Boxer Asset Management Inc.; LEWIS JOSEPH; Boxer Capital, LLC","owner_display_name":"Davis Aaron I.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":6323359.0,"shares_owned_after_display":"6,323,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-17","scope":"insider"},{"id":4760091,"accession":"0000899243-21-017115","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-017115","line_url":"/filing/0000899243-21-017115#line-3","is_derivative":false,"issuer_cik":"0001465914","issuer_name":"Rain Therapeutics Inc.","issuer_ticker":"RAIN","issuer_name_source":null,"issuer_url":"/issuer/0001465914","owner_cik":null,"owner_name":"MVA Investors, LLC; Davis Aaron I.","owner_display_name":"MVA Investors, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1025000.0,"shares_display":"1,025,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":17425000.0,"total_display":"17,425,000.00","total_whole":"17,425,000","shares_owned_after":1175000.0,"shares_owned_after_display":"1,175,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-27","filed_date":"2021-04-27","scope":"insider"},{"id":4760087,"accession":"0000899243-21-017115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-017115","line_url":"/filing/0000899243-21-017115","is_derivative":false,"issuer_cik":"0001465914","issuer_name":"Rain Therapeutics Inc.","issuer_ticker":"RAIN","issuer_name_source":null,"issuer_url":"/issuer/0001465914","owner_cik":null,"owner_name":"MVA Investors, LLC; Davis Aaron I.","owner_display_name":"MVA Investors, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":16.155,"price_display":"16.16","price_state":"stated","total_value":2423250.0,"total_display":"2,423,250.00","total_whole":"2,423,250","shares_owned_after":150000.0,"shares_owned_after_display":"150,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-23","filed_date":"2021-04-27","scope":"insider","n_lines":2},{"id":4350749,"accession":"0000899243-21-010812","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-21-010812","line_url":"/filing/0000899243-21-010812","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Fuglesang Christopher; LIEBERBURG IVAN M; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LEWIS JOSEPH; Davis Aaron I.; Boxer Capital, LLC","owner_display_name":"MVA Investors, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400005.0,"shares_display":"400,005","price_per_share":181.14999812502344,"price_display":"181.15","price_state":"stated","total_value":72460905.0,"total_display":"72,460,905.00","total_whole":"72,460,905","shares_owned_after":2000000.0,"shares_owned_after_display":"2,000,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-09","scope":"insider","n_lines":4},{"id":2908017,"accession":"0000899243-20-030060","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-030060","line_url":"/filing/0000899243-20-030060","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"Mirati Therapeutics, Inc.","issuer_ticker":"MRTX","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"LEWIS JOSEPH; Boxer Asset Management Inc.; Dissanayake Shehan Bharatha; LIEBERBURG IVAN M; Davis Aaron I.; Boxer Capital, LLC; MVA Investors, LLC; Fuglesang Christopher","owner_display_name":"LEWIS JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":202.0,"price_display":"202.00","price_state":"stated","total_value":80800000.0,"total_display":"80,800,000.00","total_whole":"80,800,000","shares_owned_after":1404610.0,"shares_owned_after_display":"1,404,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-30","filed_date":"2020-10-30","scope":"insider","n_lines":2},{"id":2968253,"accession":"0001209191-20-052341","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-052341","line_url":"/filing/0001209191-20-052341#line-1","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"Boxer Capital, LLC; Davis Aaron I.; LEWIS JOSEPH; Boxer Asset Management Inc.; MVA Investors, LLC","owner_display_name":"Boxer Capital, LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":950000.0,"shares_display":"950,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":17100000.0,"total_display":"17,100,000.00","total_whole":"17,100,000","shares_owned_after":950000.0,"shares_owned_after_display":"950,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-25","filed_date":"2020-09-29","scope":"insider"},{"id":2207958,"accession":"0000899243-20-020687","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-020687","line_url":"/filing/0000899243-20-020687#line-4","is_derivative":false,"issuer_cik":"0001015747","issuer_name":"iTeos Therapeutics, Inc.","issuer_ticker":"ITOS","issuer_name_source":null,"issuer_url":"/issuer/0001015747","owner_cik":null,"owner_name":"MVA Investors, LLC; Boxer Asset Management Inc.; LEWIS JOSEPH; Boxer Capital, LLC","owner_display_name":"MVA Investors, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1401448.0,"shares_display":"1,401,448","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":26627512.0,"total_display":"26,627,512.00","total_whole":"26,627,512","shares_owned_after":4345016.0,"shares_owned_after_display":"4,345,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-28","filed_date":"2020-07-29","scope":"insider"}],"collapsed":true,"next_cursor":"2020-07-28|2207958","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819133","name":"Tango Therapeutics, Inc.","url":"/issuer/0001819133","role":"Ten percent owner, Other","n_filings":8,"first_seen":"2022-10-13","last_seen":"2024-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001576263","name":"Mirati Therapeutics, Inc.","url":"/issuer/0001576263","role":"Ten percent owner, Other","n_filings":8,"first_seen":"2013-10-28","last_seen":"2023-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001863127","name":"Tyra Biosciences, Inc.","url":"/issuer/0001863127","role":"Ten percent owner","n_filings":2,"first_seen":"2021-09-17","last_seen":"2023-02-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001808865","name":"iTeos Therapeutics, Inc.","url":"/issuer/0001808865","role":"Ten percent owner","n_filings":2,"first_seen":"2020-07-29","last_seen":"2022-01-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001724979","name":"Rain Therapeutics Inc.","url":"/issuer/0001724979","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2021-04-27","last_seen":"2021-04-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001699382","name":"PMV Pharmaceuticals, Inc.","url":"/issuer/0001699382","role":"Other","n_filings":1,"first_seen":"2020-09-29","last_seen":"2020-09-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001807901","name":"Pandion Therapeutics, Inc.","url":"/issuer/0001807901","role":"Ten percent owner","n_filings":1,"first_seen":"2020-07-21","last_seen":"2020-07-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001485003","name":"Eleven Biotherapeutics, Inc.","url":"/issuer/0001485003","role":"Ten percent owner","n_filings":1,"first_seen":"2016-06-14","last_seen":"2016-06-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001563855","name":"SOPHIRIS BIO INC.","url":"/issuer/0001563855","role":"Ten percent owner","n_filings":2,"first_seen":"2013-08-20","last_seen":"2014-12-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001468223","retrieved_at":"2026-08-22T09:35:08+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}